Latest Pharmaroth Labs Inc. (ROTH) Headlines Ph
Post# of 50
Posted On: 03/11/2014 5:35:51 AM
Latest Pharmaroth Labs Inc. (ROTH) Headlines
PharmaRoth Labs Completes First Shipment With Mexican Distributor
Marketwire - Mon Aug 19, 3:16PM CDT
PharmaRoth Labs, Inc. (OTC Pink: ROTH), the exclusive producer and marketer of Sucanon(R), an oral Type-II Diabetes treatment, announced that it has shipped the first order from their new Mexican distributor Marcas de Renombre.
PharmaRoth Labs Completes First Shipment with New Mexican Distributor
ACCESSWIRE - Mon Aug 19, 8:05AM CDT
Las Vegas, NV, August 19, 2013 - (Accesswire) - PharmaRoth Labs, Inc. (OTCPink: ROTH) the exclusive producer and marketer of Sucanon[R], an oral Type-II Diabetes treatment, announced that it has shipped the first order from their new Mexican distributor Marcas de Renombre.
PharmaRoth Labs Welcomes Two Respected Physicians to Board of Advisors
PR Newswire - Wed Jun 05, 7:30AM CDT
PharmaRoth Labs, Inc. (OTCPink: ROTH), the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, is pleased to introduce the two newest members of the Company's Board of Advisors, Dr. Jose Alberto Rojas Jimenez and Dr. Alberto Meraz Soria. Dr. Rojas Jimenez recently concluded a clinical trial of Sucanon® on 98 Hispanic pre-diabetic patients, and the findings of the study are to be presented at the European Association for the Study of Diabetes Annual Meeting in Barcelona, Spain on September 23-27, 2013.
PharmaRoth Labs Signs Definitive Distribution Agreement in Mexico
PR Newswire - Tue May 28, 7:30AM CDT
PharmaRoth Labs, Inc. (OTC Pink: ROTH) the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, announced today that it has entered into a definitive agreement with Marcas de Renombre, S.A de C.V. granting Marcas exclusive rights for the commercialization and distribution of Sucanon® in Mexico. The agreement is for 50 years with annual sales increases conditional for continuance of exclusivity, with the first shipment anticipated in June.
PharmaRoth Labs Completes First Shipment With Mexican Distributor
Marketwire - Mon Aug 19, 3:16PM CDT
PharmaRoth Labs, Inc. (OTC Pink: ROTH), the exclusive producer and marketer of Sucanon(R), an oral Type-II Diabetes treatment, announced that it has shipped the first order from their new Mexican distributor Marcas de Renombre.
PharmaRoth Labs Completes First Shipment with New Mexican Distributor
ACCESSWIRE - Mon Aug 19, 8:05AM CDT
Las Vegas, NV, August 19, 2013 - (Accesswire) - PharmaRoth Labs, Inc. (OTCPink: ROTH) the exclusive producer and marketer of Sucanon[R], an oral Type-II Diabetes treatment, announced that it has shipped the first order from their new Mexican distributor Marcas de Renombre.
PharmaRoth Labs Welcomes Two Respected Physicians to Board of Advisors
PR Newswire - Wed Jun 05, 7:30AM CDT
PharmaRoth Labs, Inc. (OTCPink: ROTH), the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, is pleased to introduce the two newest members of the Company's Board of Advisors, Dr. Jose Alberto Rojas Jimenez and Dr. Alberto Meraz Soria. Dr. Rojas Jimenez recently concluded a clinical trial of Sucanon® on 98 Hispanic pre-diabetic patients, and the findings of the study are to be presented at the European Association for the Study of Diabetes Annual Meeting in Barcelona, Spain on September 23-27, 2013.
PharmaRoth Labs Signs Definitive Distribution Agreement in Mexico
PR Newswire - Tue May 28, 7:30AM CDT
PharmaRoth Labs, Inc. (OTC Pink: ROTH) the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, announced today that it has entered into a definitive agreement with Marcas de Renombre, S.A de C.V. granting Marcas exclusive rights for the commercialization and distribution of Sucanon® in Mexico. The agreement is for 50 years with annual sales increases conditional for continuance of exclusivity, with the first shipment anticipated in June.
(0)
(0)PharmaRoth Labs, Inc. (ROTH) Stock Research Links
Scroll down for more posts ▼